CN103961491A - Traditional Chinese medicine for treating amblyopia - Google Patents
Traditional Chinese medicine for treating amblyopia Download PDFInfo
- Publication number
- CN103961491A CN103961491A CN201410224191.XA CN201410224191A CN103961491A CN 103961491 A CN103961491 A CN 103961491A CN 201410224191 A CN201410224191 A CN 201410224191A CN 103961491 A CN103961491 A CN 103961491A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- chinese medicine
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine, and particularly relates to a traditional Chinese medicine for treating amblyopia. The traditional Chinese medicine for treating amblyopia is characterized by being mainly prepared from the following raw materials in parts by weight: 2-5 parts of mint, 2-5 parts of chrysanthemum, 1-3 parts of astragalus membranaceus, 2-4 parts of angelica sinensis, 2-5 parts of mulberry leaf, 1-4 parts of concha haliotidis, 1-3 parts of salviae miltiorrhizae, 2-4 parts of ecristate corydalis herb, 2-5 parts of three-coloured amaranth seed, 3-6 parts of smallflower galinsoga flower, 2-3 parts of spina date seed, 2-5 parts of japanese raspberry root, 3-4 parts of achyranthes root, 1-3 parts of self heal, 2-3 parts of pulp of dogwood fruit, 1-2 parts of mimosa pudica, 1-4 parts of radix bupleuri, 3-6 parts of patrinia scaniosaefolia, 1-3 parts of rhizoma acori graminei, 2-3 parts of poria cocos and 2-5 parts of cistanche salsa. The traditional Chinese medicine is significant in curative effect, has the effects of nourishing yin, nourishing the liver and improving eyesight, and is free of toxic and side effects, the eye development process of a sufferer is improved, the living quality of a patient is improved, the patient can be secure to take, and the total effective rate can be up to 98%.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of amblyopia.
(1) background technology
All eyes without organic disease, correcting defects of vision is called amblyopia lower than 0.9.Amblyopia is the common eye diseases in children of clinical ophthalmology, sickness rate is 3% left and right, it is infant period, because a variety of causes fails to accept the suitable stimulation of looking as reasons such as consciousness, motion, conduction and the visual center, the state that the visual performance that visual development is affected and occur goes down, main manifestations is visual disturbance and binocular vision obstacle, amblyopia is not only damaged child's vision, and can make child lose stereoscopic vision, multiple occupation and the work post such as not competent high-tech area after growing up.Cause is the fastest period of visual development in critical period (before 3 years old) and the sensitive period (6~8 years old) of visual development; also be that vision is suffering abnormal environment to stimulate the period that the most easily produces permanent lesion simultaneously; therefore, timely correction of refractive errors, anisometropia, stravismus and to remove visual deprivation factor be the basic way that prevention amblyopia occurs within critical period of visual development and sensitive period.
In recent years, the traditional Chinese medical science is cured amblyopia and has been obtained certain effect, and the Integral Concept of the traditional Chinese medical science and dialectical treating have been brought into play good effect, are more and more approved by people.
(2) summary of the invention
The Chinese medicine of the treatment amblyopia that the invention provides a kind of good effect, fill a prescription rationally, has no side effect.
The present invention is achieved through the following technical solutions:
Treat a medicine for amblyopia, its special character is: the raw material composition that mainly contains following weight fraction:
2 ~ 5 parts of Herba Menthaes, 2 ~ 5 parts of Flos Chrysanthemis, 1 ~ 3 part of the Radix Astragali,
2 ~ 4 parts of Radix Angelicae Sinensis, 2 ~ 5 parts, Folium Mori, 1 ~ 4 part of Concha Haliotidis,
1 ~ 3 part of Radix Salviae Miltiorrhizae, 2 ~ 4 parts of Herba Corydalis tailensiss, 2 ~ 5 parts of Semen Amaranthi tricoloris,
3 ~ 6 parts of Flos Galinsogae Parvifloraes, 2 ~ 3 parts of Semen Ziziphi Spinosaes, 2 ~ 5 parts of Radix Rubi Parvifoliis,
3 ~ 4 parts of Radix Achyranthis Bidentataes, 1 ~ 3 part of Spica Prunellae, 2 ~ 3 parts of Fructus Corni,
1 ~ 2 part of Herba Mimosae Pudicae, 1 ~ 4 part of Radix Bupleuri, 3 ~ 6 parts of Herba Patriniaes,
1 ~ 3 part of Rhizoma Acori Graminei, 2 ~ 3 parts, Poria, 2 ~ 5 parts of Herba Cistanches.
Compound method of the present invention is as follows: medicinal boiled water immersion in above-mentioned was decocted after 1 hour, and when decoction, moisture content exceedes Chinese medicine 3-5 centimetre, uses slow fire boiling after 40 minutes after water seethes with excitement, and filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.
1, clinical observation:
(1) physical data:
The inventor in 2010 so far, chooses 158 routine patients and carries out clinical observation treatment.Age 6 is to 22 years old, wherein male 81 examples, female's 77 examples.
(2) Therapeutic Method:
With being decocted in water for oral dose, sooner or later respectively once, it within 30 days, is a course for the treatment of with medicine of the present invention, according to the state of an illness and do not recover speed treatment 1-10 month not etc.
(3) efficacy assessment standard:
The present invention is mainly used in treating amblyopia, therefore amblyopia symptom improvement situation and every detection index are as curative effect judging standard, is divided into following four kinds:
Cure: clinical symptom disappearance, vision restoration are more than 0.8.
Effective: clinical symptom disappearance, vision is obviously improved.
Effective: clinical symptoms, vision are all improved.
Invalid: clinical symptoms and vision are unchanged.
(4) therapeutic effect:
Cure 141 examples, effective 10 examples, effective 5 examples, invalid 2 examples, all cases all have no adverse reaction.
The present invention is evident in efficacy, have YIN nourishing, nourishing the liver, improving eyesight effect, improve patient's eye developmental process, improved patient's quality of life; And it has no side effect, patient can feel at ease to take, and total effective rate reaches 98%.
Detailed description of the invention
Embodiment 1:
By 2 grams of Herba Menthaes, 2 grams of Flos Chrysanthemis, 1 gram of the Radix Astragali, 2 grams of Radix Angelicae Sinensis, 2 grams, Folium Mori, 1 gram of Concha Haliotidis, 1 gram of Radix Salviae Miltiorrhizae, 2 grams of Herba Corydalis tailensiss, 2 grams of Semen Amaranthi tricoloris, 3 grams of Flos Galinsogae Parvifloraes, 2 grams of parts of Semen Ziziphi Spinosae, 2 grams of Radix Rubi Parvifoliis, 3 grams of Radix Achyranthis Bidentataes, 1 gram of Spica Prunellae, 2 grams of Fructus Corni, 1 gram of Herba Mimosae Pudicae, 1 gram of Radix Bupleuri, 3 grams of Herba Patriniaes, 1 gram of Rhizoma Acori Graminei, 2 grams, Poria, 2 grams of Herba Cistanches soak after 1 hour and decoct with boiled water, and when decoction, moisture content exceedes 3 centimeters, Chinese medicine, after water boiling, use slow fire boiling after 40 minutes, filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.
Embodiment 2:
By 3 grams of Herba Menthaes, 3 grams of Flos Chrysanthemis, 2 grams of the Radixs Astragali, 3 grams of Radix Angelicae Sinensis, 3 grams, Folium Mori, 3 grams of Concha Haliotidis, 2 grams of Radix Salviae Miltiorrhizaes, 3 grams of Herba Corydalis tailensiss, 3 grams of Semen Amaranthi tricoloris, 4 grams of Flos Galinsogae Parvifloraes, 3 grams of Semen Ziziphi Spinosaes, 3 grams of Radix Rubi Parvifoliis, 4 grams of Radix Achyranthis Bidentataes, 2 grams of Spica Prunellaes, 3 grams of Fructus Corni, 2 grams of Herba Mimosae Pudicaes, 3 grams of Radix Bupleuri, 5 grams of Herba Patriniaes, 2 grams of Rhizoma Acori Graminei, 3 grams, Poria, 3 grams of Herba Cistanches soak after 1 hour and decoct with boiled water, and when decoction, moisture content exceedes 4 centimeters, Chinese medicine, after water boiling, use slow fire boiling after 40 minutes, filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.
Embodiment 3:
By 5 grams of Herba Menthaes, 5 grams of Flos Chrysanthemis, 3 grams of the Radixs Astragali, 4 grams of Radix Angelicae Sinensis, 5 grams, Folium Mori, 4 grams of Concha Haliotidis, 3 grams of Radix Salviae Miltiorrhizaes, 4 grams of Herba Corydalis tailensiss, 5 grams of Semen Amaranthi tricoloris, 6 grams of Flos Galinsogae Parvifloraes, 3 grams of Semen Ziziphi Spinosaes, 5 grams of Radix Rubi Parvifoliis, 4 grams of Radix Achyranthis Bidentataes, 3 grams of Spica Prunellaes, 3 grams of Fructus Corni, 2 grams of Herba Mimosae Pudicaes, 4 grams of Radix Bupleuri, 6 grams of Herba Patriniaes, 3 grams of Rhizoma Acori Graminei, 3 grams, Poria, 5 grams of Herba Cistanches soak after 1 hour and decoct with boiled water, and when decoction, moisture content exceedes 5 centimeters, Chinese medicine, after water boiling, use slow fire boiling after 40 minutes, filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.
Claims (1)
1. a Chinese medicine for the treatment of amblyopia, is characterized in that: the raw material composition that mainly contains following weight fraction:
2 ~ 5 parts of Herba Menthaes, 2 ~ 5 parts of Flos Chrysanthemis, 1 ~ 3 part of the Radix Astragali,
2 ~ 4 parts of Radix Angelicae Sinensis, 2 ~ 5 parts, Folium Mori, 1 ~ 4 part of Concha Haliotidis,
1 ~ 3 part of Radix Salviae Miltiorrhizae, 2 ~ 4 parts of Herba Corydalis tailensiss, 2 ~ 5 parts of Semen Amaranthi tricoloris,
3 ~ 6 parts of Flos Galinsogae Parvifloraes, 2 ~ 3 parts of Semen Ziziphi Spinosaes, 2 ~ 5 parts of Radix Rubi Parvifoliis,
3 ~ 4 parts of Radix Achyranthis Bidentataes, 1 ~ 3 part of Spica Prunellae, 2 ~ 3 parts of Fructus Corni,
1 ~ 2 part of Herba Mimosae Pudicae, 1 ~ 4 part of Radix Bupleuri, 3 ~ 6 parts of Herba Patriniaes,
1 ~ 3 part of Rhizoma Acori Graminei, 2 ~ 3 parts, Poria, 2 ~ 5 parts of Herba Cistanches.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410224191.XA CN103961491A (en) | 2014-05-26 | 2014-05-26 | Traditional Chinese medicine for treating amblyopia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410224191.XA CN103961491A (en) | 2014-05-26 | 2014-05-26 | Traditional Chinese medicine for treating amblyopia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103961491A true CN103961491A (en) | 2014-08-06 |
Family
ID=51231811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410224191.XA Pending CN103961491A (en) | 2014-05-26 | 2014-05-26 | Traditional Chinese medicine for treating amblyopia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103961491A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105851362A (en) * | 2016-03-30 | 2016-08-17 | 黄山树德堂食品饮料有限公司 | Blood nourishing and kidney benefiting, and liver clearing and eyesight improving chrysanthemum health-care tea and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1178682A (en) * | 1996-10-07 | 1998-04-15 | 郭书文 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
KR20110054579A (en) * | 2009-11-18 | 2011-05-25 | 강홍구 | Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery |
-
2014
- 2014-05-26 CN CN201410224191.XA patent/CN103961491A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1178682A (en) * | 1996-10-07 | 1998-04-15 | 郭书文 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
KR20110054579A (en) * | 2009-11-18 | 2011-05-25 | 강홍구 | Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105851362A (en) * | 2016-03-30 | 2016-08-17 | 黄山树德堂食品饮料有限公司 | Blood nourishing and kidney benefiting, and liver clearing and eyesight improving chrysanthemum health-care tea and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102512603B (en) | Traditional Chinese medicinal composition for treating acute infectious conjunctivitis | |
CN101559195B (en) | Epilepsy therapy capsule and preparation method thereof | |
CN101954028A (en) | Medicinal pillow for preventing and treating myopic eyes | |
CN100364593C (en) | Oral liquid for promoting eyesight and protecting eye | |
CN103735790A (en) | Traditional Chinese medicine composition for treating tinnitus | |
CN102670993B (en) | Traditional Chinese medicine for treating cataract | |
CN102091214A (en) | Medicament for improving eyesight | |
CN103961531A (en) | Traditional Chinese medicine for treating palpitation | |
CN103961491A (en) | Traditional Chinese medicine for treating amblyopia | |
CN102000279B (en) | Traditional Chinese medicine for treating myopia eye diseases | |
CN101797314B (en) | Medicinal composition for treating adolescent myopia and preparation method thereof | |
CN103720922A (en) | Traditional Chinese medicinal decoction for treating keratitis | |
CN102813757B (en) | Preparation method of traditional Chinese medicine for treating lumbago type acute glomerulonephritis | |
CN105596544A (en) | Improved capsules capable of tonifying liver and improving eyesight | |
CN103721020A (en) | Blood circulation promoting and meridian unlocking granule for treating cerebral thrombosis and preparation method of granule | |
CN107715095A (en) | A kind of Chinese medicine preparation for treating paediatrics cough with lung heat | |
CN104189623A (en) | Traditional Chinese medicine used for treating trachoma | |
CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
CN115444903A (en) | Application of rehabilitation eyesight oral liquid in preparation of eyesight improving medicine | |
CN103961492A (en) | Traditional Chinese medicine for treating glaucoma | |
CN102727675B (en) | Traditional Chinese medicine capsules used for treating nasal sinusitis | |
CN101843786A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
CN105288229A (en) | Traditional Chinese medicine composition for treating nystagmus | |
CN103977287A (en) | Traditional Chinese medicine for treating viral myocarditis | |
CN105687775A (en) | Traditional Chinese medicine composition for treating keratohelcosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140806 |
|
RJ01 | Rejection of invention patent application after publication |